Gevo, Inc. current report, 30 December 2023

Gevo, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Gevo, Inc. on December 30, 2023, covering events effective as of January 2, 2024. The filing primarily addresses corporate governance changes regarding the Board of Directors.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on director appointments and compensation arrangements rather than financial performance.

Material Changes

The Board of Directors approved the appointment of Mary Kathryn (Katie) Ellet as a Class III director, effective January 2, 2024. Her term will expire at the 2025 annual meeting of stockholders. The Board determined that Ms. Ellet qualifies as an independent director under Nasdaq listing standards.

Compensation and Governance Details

  • Cash Retainer: Ms. Ellet will receive an annual cash retainer of $85,000.
  • Equity Grant: An initial equity grant valued at $73,500 will be issued pursuant to the Amended and Restated 2010 Stock Incentive Plan.
  • Future Compensation: She is eligible for annual equity grants and other compensation consistent with the Company's policy for non-employee directors.
  • Indemnification: Ms. Ellet entered into the Company's customary form of indemnification agreement.

The filing states there are no understandings or arrangements with any person regarding her selection, and no related party transactions requiring reporting under Item 404(a) of Regulation S-K exist.

Investor Verification Checklist

  • Verify the independence status of the new director against current Nasdaq listing standards.
  • Review the Company's Amended and Restated 2010 Stock Incentive Plan to understand the vesting terms of the $73,500 equity grant.
  • Confirm the total number of authorized shares remaining in the stock incentive plan following this grant.
  • Check for any subsequent filings regarding the 2025 annual meeting of stockholders where Ms. Ellet's term will expire.